It comes as drugmakers brace for Trump’s levies on pharmaceuticals imported into the U.S. – his administration’s bid to boost manufacturing in the country.
Related Posts
Inside GM’s decade-long battle to revive Cadillac as the quintessential American luxury car brand
Here’s how the brand is trying to get its portfolio back into shape and boost its status in the competitive luxury vehicle market.
Merck plans $3 billion cost cuts by end of 2027, narrows full-year outlook
The multi-year effort comes as Merck prepares to offset revenue losses from the upcoming patent expiration of its blockbuster cancer drug Keytruda.
Home price hikes are slowing more than expected
Home prices are starting to weaken due to higher mortgage rates, more supply on the market and waning demand from homebuyers concerned about the economy.